Galapagos - Strong buy PT $240 > $480We think Galapagos is undervalued at current levels. The price will be heading $240 soon.
Cup and Handle formation.
The RSI / MACD and volume showing signs of recovery from recent 60% correction.
First price target: $ 240
Second price target: $350 - $480 (2022/23)
Full year 2020 results:
18 Febuary 2021
Webcast 19 February 2021, 14.00 CET
Events:
January 27, 2021
Degroof Petercam Healthcare Conference
February 23, 2021
10th Annual SVB Leerink Global Healthcare Conference 2021
March 01, 2021
Raymond James virtual Institutional Investors Conference
March 01, 2021
Cowen 41st Annual Health Care Conference
March 02, 2021
Credit Suisse London 2021 Healthcare Conference
March 09, 2021
Barclays Global Healthcare Conference
May 05, 2021
Kempen’s Life Sciences Conference
May 11, 2021
BofA Global Research 2021 Health care conference
June 15, 2021
Citi 10th Annual European Healthcare Conference
September 08, 2021
Citi Global Biopharma Conference
September 22, 2021
Bernstein’s 18th Annual Strategic Decisions Conference (SDC)
November 16, 2021
Stifel 2021 Healthcare Conference
Aexid
DSM - Oversold. Price target: € 120 - 130We think DSM Koninklijke AEX:DSM is oversold at this point. Possible bounce back to €120.
Long term price target is €130 - €140.